View in EDS

Established and Emerging Therapies for High-Risk Neuroblastoma.

Saved in:
Bibliographic Details
Title: Established and Emerging Therapies for High-Risk Neuroblastoma.
Authors: Xu S; Texas Children's Hospital, Baylor College of Medicine, Houston, TX, USA., Foster J; Texas Children's Hospital, Baylor College of Medicine, Houston, TX, USA. jhfoster@bcm.edu., Wahba A; Texas Children's Hospital, Baylor College of Medicine, Houston, TX, USA.
Source: Paediatric drugs [Paediatr Drugs] 2026 Mar; Vol. 28 (2), pp. 159-175. Date of Electronic Publication: 2026 Feb 26.
Publication Type: Journal Article; Review
Journal Info: Publisher: Springer International Country of Publication: Switzerland NLM ID: 100883685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-2019 (Electronic) Linking ISSN: 11745878 NLM ISO Abbreviation: Paediatr Drugs Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41746475
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Established and Emerging Therapies for High-Risk Neuroblastoma.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Xu+S%22">Xu S</searchLink>; Texas Children's Hospital, Baylor College of Medicine, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Foster+J%22">Foster J</searchLink>; Texas Children's Hospital, Baylor College of Medicine, Houston, TX, USA. jhfoster@bcm.edu.<br /><searchLink fieldCode="AU" term="%22Wahba+A%22">Wahba A</searchLink>; Texas Children's Hospital, Baylor College of Medicine, Houston, TX, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22100883685%22">Paediatric drugs</searchLink> [Paediatr Drugs] 2026 Mar; Vol. 28 (2), pp. 159-175. <i>Date of Electronic Publication: </i>2026 Feb 26.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Review
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer+International%22">Springer International </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>100883685 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1179-2019 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2211745878%22">11745878 </searchLink><i>NLM ISO Abbreviation: </i>Paediatr Drugs <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41746475
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s40272-025-00731-4
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 159
    Titles:
      – TitleFull: Established and Emerging Therapies for High-Risk Neuroblastoma.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Xu S
      – PersonEntity:
          Name:
            NameFull: Foster J
      – PersonEntity:
          Name:
            NameFull: Wahba A
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 03
              Text: 2026 Mar
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1179-2019
          Numbering:
            – Type: volume
              Value: 28
            – Type: issue
              Value: 2
          Titles:
            – TitleFull: Paediatric drugs
              Type: main
ResultId 1